Mark S. Klempner MD

Mark S. Klempner, MD, is the executive vice chancellor for MassBiologics and professor of medicine at UMass Medical School. Dr. Klempner joined UMMS in July 2012 from the Boston University School of Medicine, where he served as associate provost for research, Conrad Wesselhoeft Professor of Medicine and the founding director of the National Emerging Infectious Diseases Laboratories.

Klempner is internationally known for basic infectious disease research and the development of therapeutics and vaccines to combat infections. From 2003 to 2011, he served as principal investigator on a grant from the National Institute of Allergy and Infectious Diseases to design the scientific programs and build one of two National Biocontainment Laboratories. Known as NEIDL, these laboratories study newly emerging infectious diseases such as hemorrhagic fever viruses and re-emerging diseases such as tuberculosis and influenza. The focus of research is on basic and translational studies leading to the development of diagnostics, therapeutics and vaccines.